Which statement best describes why local vasodilation is advantageous for targeted tissue perfusion?

Which statement best describes why local vasodilation is advantageous for targeted tissue perfusion?

• A. It increases heart rate.
• B. It reduces overall perfusion to non-target tissues.
• C. It increases vascular resistance in non-target tissues.
• D. It can alter flow without stressing the heart.

Answer: (D)

The main concept is that local vasodilation lowers resistance in the arterioles feeding a specific tissue, which increases blood flow to that area without requiring the heart to work harder. By opening up the local vascular bed, the flow to the target tissue rises because the same pressure difference drives more volume through a lower-resistance pathway. This redistribution of flow means you boost perfusion where it’s needed while keeping overall cardiac workload relatively unchanged, so the heart isn’t stressed by a global increase in output. That’s why this mechanism is advantageous for targeted perfusion. The other ideas don’t fit as well: increasing heart rate isn’t the primary outcome of local vasodilation; it’s about changing where blood goes, not how fast the heart beats. Reducing overall perfusion to non-target tissues isn’t the goal—perfusion is redistributed, not necessarily reduced across the whole system. Increasing vascular resistance in non-target tissues would counteract the purpose of directing more flow to the target area.

The main concept is that local vasodilation lowers resistance in the arterioles feeding a specific tissue, which increases blood flow to that area without requiring the heart to work harder. By opening up the local vascular bed, the flow to the target tissue rises because the same pressure difference drives more volume through a lower-resistance pathway. This redistribution of flow means you boost perfusion where it’s needed while keeping overall cardiac workload relatively unchanged, so the heart isn’t stressed by a global increase in output. That’s why this mechanism is advantageous for targeted perfusion.

The other ideas don’t fit as well: increasing heart rate isn’t the primary outcome of local vasodilation; it’s about changing where blood goes, not how fast the heart beats. Reducing overall perfusion to non-target tissues isn’t the goal—perfusion is redistributed, not necessarily reduced across the whole system. Increasing vascular resistance in non-target tissues would counteract the purpose of directing more flow to the target area.